TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/24 20:00 | 11/8/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | M.d | 294 | 8.17 | 0 | 36 | 0 | D | |||||||||||||||
11/13/24 20:00 | 11/8/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | S.d | -576 | 16.00 | 0 | -36 | -100 | 0 | D | ||||||||||||||
10/18/24 20:00 | 10/16/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | S.d | -2,855 | 13.67 | 0 | -209 | -100 | 0 | D | ||||||||||||||
10/18/24 20:00 | 10/16/24 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | M.d | 371 | 2.88 | 0 | 129 | 0 | D | |||||||||||||||
2/17/23 20:05 | 2/16/23 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | S.d | -41 | 4.03 | 0 | -10 | -11 | 80 | D | ||||||||||||||
5/6/22 19:00 | 5/5/22 | WVE | Wave Life Sciences Ltd. | U0 | Health | Drug | Pharmaceutical Preparations | Francis Chris | MA | O | See Rema | S | -19 | 1.72 | 0 | -11 | -11 | 90 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |